A Nevada jury is ordering pharmaceutical companies to pay $162.5 million in punitive damages in a lawsuit stemming from a Las Vegas hepatitis C outbreak in 2008.
The damages awarded Monday in Clark County District Court are on top of the $20.1 million in compensatory damages awarded to five plaintiffs Thursday after a jury found Teva Parenteral Medicines Inc., Baxter Healthcare Corp. and McKesson Corp. liable after a seven-week trial.
Plaintiffs’ lawyers had been seeking $600 million in punitive damages.
At least one of the drug companies is planning an immediate appeal.
Plaintiffs accused the drug companies of distributing dangerously large vials of the powerful anesthetic propofol to clinics where doctors and anesthesiologists are suspected of reusing vials – despite warnings that the practice could spread blood-borne diseases.
Was this article valuable?
Here are more articles you may enjoy.
AI Weather Models Have Shown Promise This Hurricane Season 
Swiss Re: Mitigating Flood Risk 10x More Cost Effective Than Rebuilding 
Fake Bear Attacks on Car for Fraudulent Insurance Claims Lead to Arrests 
US Opens Probe into Over 110,000 Ford SUVs on Seat Belt Concern 
Want to stay up to date?
Get the latest insurance news
sent straight to your inbox.